Google
LNAI 株価分析 — Lunai Bioworks Inc. (Healthcare >> Biotechnology)
LNAI に関するよくある質問
LNAIのPER（株価収益率）は？
Lunai Bioworks Inc.（LNAI）は現在PER 3.99倍で取引されています。
LNAIのROE（自己資本利益率）は？
Lunai Bioworks Inc.のROEは1,342.81%です。
LNAIの配当利回りは？
Lunai Bioworks Inc.の配当利回りは0.00%です。
LNAIの品質スコア（Quality Score）は？
当社のAIはLNAIの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
LNAIは今が買い時ですか？
当社AIのタイミングスコアは100点中69点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
LNAIはどのセクターに属しますか？
Lunai Bioworks Inc.はHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
LNAI AI Analysis Summary
Our AI summary for LNAI: Lunai Bioworks Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 3.99, ROE of 1,342.81%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 2.42
Price
-0.06
(-2.42%)
Day Change
|
|
|---|
LNAI, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 85 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.42 |
| PBV / Sector |
-1.18 / 5.21
|
| Earning Per Share | -27.61 |
| PE / Sector |
3.99 / 21.00
GREAT
|
| PEG or PE/Growth / Sector |
-0.60 / 1.11
|
| Average 1M Daily Value |
1.15 M
GREAT
|
| Average 1W Daily Value |
4.36 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-07 08:11:57 |
| Symbol | LNAI |
| Name | LUNAI BIOWORKS INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 4.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11.24 / 9,672.56 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2080 Century Park East, Los Angeles, CA, United States, 90067
Phone: 305 918 1980
Website: https://www.lunaibioworks.com
Sector: Healthcare >> Biotechnology
Description: Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
